Table 3.

Changes in BMLs and clinical symptoms as a response to weight loss

	Per protocol analyses		Per protocol analyses
	Patients with baseline BML score ≥ 0		Patients with baseline BML score > 0
	N = 169		N = 139
	Weight loss	Weight loss	Weight loss	Weight loss
	< 10 %	≥ 10 %	< 10 %	≥ 10 %
Change in the sum of all BML scores
Responders	N = 5 (15 %)	N = 34 (25 %)	N = 5 (20 %)	N = 34 (30 %)
Non-responders	N = 29 (85 %)	N = 101 (75 %)	N = 20 (80 %)	N = 80 (70 %)
Change in the maximum BML score
Responders	N = 5 (15 %)	N = 23 (17 %)	N = 5 (20 %)	N = 23 (20 %)
Non-responders	N = 29 (85 %)	N = 112 (83 %)	N = 20 (80 %)	N = 91 (80 %)
OMERACT-OARSI response
Responders	N = 16 (47 %)	N = 103 (76 %)	N = 13 (52 %)	N = 87 (76 %)
Non-responders	N = 18 (53 %)	N = 32 (24 %)	N = 12 (48 %)	N = 27 (32 %)